Asbestos exposure has had a devastating impact on over 730,000 families to date and it is estimated that the final number of mesothelioma lawsuits will exceed 3 million before every person who has developed an asbestos related illness comes forward with a claim. The fact that many of the companies that used asbestos laced products or produced them were fully aware of the negative health consequences makes asbestos litigation that much more heated. Chicago Mesothelioma Lawyers are dedicated to holding those companies accountable for putting employees and their families in harm’s way without any remorse in doing so.
Why a Different Approach is required for Mass Tort Claims
A mass tort is the definition of litigation that involves an extremely large number of plaintiffs and, in most cases, multiple defendants. Asbestos exposure has resulted in the largest mass tort in history and over 8,400 different companies have been brought to court because their products or policies exposed employees to asbestos over a prolonged period of time— resulting in the development of painful and deadly medical conditions. Because each asbestos case involves multiple defendants, it can be difficult determining who to sue and the amount of damages to seek from each defendant. Chicago Mesothelioma Lawyers is a law firm that has access to knowledgeable and experienced attorneys who will be able to determine the most efficient and effective approach to your case that will yield the maximum claim.
Avoiding Settlements that are not in Your Best Interest
Many mesothelioma cases settle out of court because companies that are responsible for asbestos exposure are fully aware of the risk that they must take if the case goes to court. Punitive damages are allowed in some jurisdictions, which increase the amount of money that may be awarded if the company is found at fault. Understand that not all settlements are in the best interest of the injured party and companies will make every attempt possible to limit the payout that they must provide. For this reason, it is important to retain representation that can provide an accurate estimate of the amount of compensation to which you are entitles and has the ability to negotiate a settlement that works to your favor and not that of the company responsible for your illness or the loss of a loved one.
Any information that you give us when you consult with one of our attorneys will be kept in strict confidence and you will not be required to pay a fee in order to retain our services. In fact, unless we are able to negotiate a settlement or win your case in court, you will not be required to pay us a dime. We are that confident in our ability to collect the maximum amount of compensation to which you are entitled that if we fail to do so, our services are free.
Due to the nature of mesothelioma, we know that you do not have that much time to act and that fighting your cancer is the most pressing concern on your mind. Contact us today and we will review your case with you and let you know what we feel the best plan of action is. We will also make every effort to get your case expedited so that you do not need to wait any longer than you need to in order to be compensated for your medical bills, time off of work and pain and suffering.
Types of Exposure
In order for a mesothelioma patient to recover damages for their illnesses, it is important to determine who the responsible parties may be. Common mesothelioma cases in Chicago include:
Mesothelioma Legal Claims
There are many issues with mesothelioma. Learn more below:
Aduro Biotech to Host and Webcast an Investor Event in Conjunction with the 2017 ASCO Annual Meeting - Nasdaq
May 26th, 2017 • Keep reading »
Yondelis Stabilized Mesothelioma in Many Patients Taking Part in Phase 2 Clinical Trial - Mesothelioma Research News
May 23rd, 2017 • Keep reading »
PharmaMar Announces New Data with its Compounds Yondelis® and Lurbinectedin During ASCO 2017 - PR Newswire (press release)
May 19th, 2017 • Keep reading »
Deficiencies in repair of DNA identified in many types of solid tumors - Science Daily
May 18th, 2017 • Keep reading »